| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant aminoglutethimide for post-menopausal women with primary breast cancer: Analysis of eight years
|
Jones, AL
|
|
1992
|
1 |
3 |
p. 160-161
2 p.
|
artikel
|
| 2 |
A flow cytometric study of adhesion molecules and oncoproteins in primary and metastatic breast cancer
|
Lawry, J.
|
|
1992
|
1 |
3 |
p. 147-
1 p.
|
artikel
|
| 3 |
Alteration of integrin and stromal protein expression — A marker of pre-malignant change?
|
Louise Jones, J.
|
|
1992
|
1 |
3 |
p. 150-
1 p.
|
artikel
|
| 4 |
Analysis of long-term prognostic factors in breast cancer
|
Jones, M
|
|
1992
|
1 |
3 |
p. 150-
1 p.
|
artikel
|
| 5 |
A prospective study of psychological morbidity in women with screen detected and symptomatic breast cancer
|
Farmer, A.J.
|
|
1992
|
1 |
3 |
p. 158-
1 p.
|
artikel
|
| 6 |
A randomised study comparing primary endocrine therapy with primary chemo-endocrine therapy given at the time of relapse in patients with breast cancer
|
Arvidson, Maria
|
|
1992
|
1 |
3 |
p. 146-
1 p.
|
artikel
|
| 7 |
A randomised trial of radiotherapy versus tamoxifen as first line treatment in locally advanced breast cancer
|
Armitage, N.C.
|
|
1992
|
1 |
3 |
p. 165-166
2 p.
|
artikel
|
| 8 |
A randomized study with 4-hydroxyandrostenedione (4-OHA) in postmenopausal advanced breast cancer (ABC): Characteristics of responsive patients
|
Bajetta, E.
|
|
1992
|
1 |
3 |
p. 160-
1 p.
|
artikel
|
| 9 |
Are you a typer, grader or a molecular convert? Prognostic assessment of operable breast carcinoma
|
Ellis, IO
|
|
1992
|
1 |
3 |
p. 159-
1 p.
|
artikel
|
| 10 |
Assessment of c-erbB-2 amplification in breast cancer by the differential PCR method
|
Hubbard, AL
|
|
1992
|
1 |
3 |
p. 164-
1 p.
|
artikel
|
| 11 |
Bibliography of the breast
|
|
|
1992
|
1 |
3 |
p. B18-B27
nvt p.
|
artikel
|
| 12 |
Biological approaches to breast cancer prevention
|
Costa, A.
|
|
1992
|
1 |
3 |
p. 119-123
5 p.
|
artikel
|
| 13 |
Breast cancer and breast feeding
|
Chilvers, CED
|
|
1992
|
1 |
3 |
p. 156-
1 p.
|
artikel
|
| 14 |
Breast cancer growth rates measured with bromodeoxyuridine
|
Stanton, PD
|
|
1992
|
1 |
3 |
p. 148-
1 p.
|
artikel
|
| 15 |
Breast cancer in the developing world — an unaddressed challenge
|
Kalache, A.
|
|
1992
|
1 |
3 |
p. 124-128
5 p.
|
artikel
|
| 16 |
Breast cancer screening: A benefit can be anticipated
|
Galea, MH
|
|
1992
|
1 |
3 |
p. 155-
1 p.
|
artikel
|
| 17 |
Breast haematoma: a rare presentation of breast cancer
|
Nathan, B.N.
|
|
1992
|
1 |
3 |
p. 135-
1 p.
|
artikel
|
| 18 |
Carcinosarcoma and the metaplastic carcinomas
|
Paterson, D.A.
|
|
1992
|
1 |
3 |
p. 136-137
2 p.
|
artikel
|
| 19 |
Cathepsin D reactivity in human breast carcinoma. Important prognostic factor or epiphenomenon
|
O'Donoghue, A.
|
|
1992
|
1 |
3 |
p. 159-
1 p.
|
artikel
|
| 20 |
Cell type specific localisation of ectoenzymes in the human breast
|
Atherton, AJ
|
|
1992
|
1 |
3 |
p. 153-
1 p.
|
artikel
|
| 21 |
C-erbB-2 expression and its importance in post menopausal patients
|
Winstanley, JHR
|
|
1992
|
1 |
3 |
p. 159-
1 p.
|
artikel
|
| 22 |
Chemoprevention of beast cancer — An update of the Royal Marsden tamoxifen trial
|
Powles, Trevor J
|
|
1992
|
1 |
3 |
p. 155-156
2 p.
|
artikel
|
| 23 |
CMF versus epirubicin in advanced breast cancer: Validating a new QoL tool
|
Fraser, SCA
|
|
1992
|
1 |
3 |
p. 146-
1 p.
|
artikel
|
| 24 |
Colour Doppler studies of axillary nodes in patients with breast cancer
|
Dixon, JM
|
|
1992
|
1 |
3 |
p. 163-
1 p.
|
artikel
|
| 25 |
Combination of the aromatase inhibitors 4-hydroxyandrostenedione (40HA) and aminogluthethimide (AG): An approach to maximization of aromatase inhibition and E2 suppression?
|
MacNeill, F
|
|
1992
|
1 |
3 |
p. 161-
1 p.
|
artikel
|
| 26 |
Confirmation of a prognostic index for breast cancer
|
Galea, MH
|
|
1992
|
1 |
3 |
p. 150-
1 p.
|
artikel
|
| 27 |
Continuous cytotoxics in responsive metastatic breast cancer: A role for tumour markers
|
Dixon, AR
|
|
1992
|
1 |
3 |
p. 146-147
2 p.
|
artikel
|
| 28 |
Delayed presentation in breast cancer: Relationship to tumour stage and outcome
|
Hainsworth, PJ
|
|
1992
|
1 |
3 |
p. 163-164
2 p.
|
artikel
|
| 29 |
Description of a germ line defect in the region of the progesterone receptor gene in patients with primary breast cancer
|
Byrne, J.
|
|
1992
|
1 |
3 |
p. 156-
1 p.
|
artikel
|
| 30 |
Diary of events
|
|
|
1992
|
1 |
3 |
p. 144-145
2 p.
|
artikel
|
| 31 |
DNA ploidy and proliferative index in breast cancer prognosis
|
Galea, MH
|
|
1992
|
1 |
3 |
p. 148-
1 p.
|
artikel
|
| 32 |
Does lactation prevent subsequent breast cancer?
|
McPherson, K.
|
|
1992
|
1 |
3 |
p. 140-
1 p.
|
artikel
|
| 33 |
Dual immunocytochemical staining of receptors for oestrogen (ER) and epidermal growth factor (EGFR) in human breast cancer
|
Sharma, AK
|
|
1992
|
1 |
3 |
p. 167-
1 p.
|
artikel
|
| 34 |
Ductal Carcinoma In-Situ Of The Breast: A new simplified histological classification. Association between cellular proliferation and c-erbB-2 protein expression
|
Poller, David N.
|
|
1992
|
1 |
3 |
p. 164-
1 p.
|
artikel
|
| 35 |
ESR, CEA, CA 15.3 & EMCA have a role in directing metastatic breast cancer therapy
|
Dixon, AR
|
|
1992
|
1 |
3 |
p. 165-
1 p.
|
artikel
|
| 36 |
European Society of Mastology (EUSOMA) Today
|
Greco, Marco
|
|
1992
|
1 |
3 |
p. 117-118
2 p.
|
artikel
|
| 37 |
Evaluation of PS2 expression in primary breast tumours: Prediction of response to endocrine therapy
|
Dookeran, K
|
|
1992
|
1 |
3 |
p. 155-
1 p.
|
artikel
|
| 38 |
Expression of four estrogen-induced (pLIV1, pS2, pSYD3 and pSYD8) and one oestrogen-repressed (pBCL1) sequence in MCF7 cells and immunodefined primary breast cancers
|
Manning, D.L.
|
|
1992
|
1 |
3 |
p. 166-167
2 p.
|
artikel
|
| 39 |
Factors influencing patients' choice of treatment in screen-detected breast cancer
|
Richards, CA
|
|
1992
|
1 |
3 |
p. 158-
1 p.
|
artikel
|
| 40 |
Flow and static cytometry in the automated analysis of grading in breast cancer
|
Galea, MH
|
|
1992
|
1 |
3 |
p. 149-150
2 p.
|
artikel
|
| 41 |
Flow cytometric detection of P-glycoprotein (P-G) in sequential fine needle aspirates (FNA) from patients receiving primary chemotherapy for operable breast cancer
|
Forouhi, P
|
|
1992
|
1 |
3 |
p. 149-
1 p.
|
artikel
|
| 42 |
Flow cytometry and the measurement of proliferative indices and PS2 expression in breast cancer
|
Keen, JC
|
|
1992
|
1 |
3 |
p. 149-
1 p.
|
artikel
|
| 43 |
High dose, dose-intensive chemotherapy with Doxorubicin and Cyclophosphamide for the treatment of advanced breast cancer
|
Ferguson, J.E.
|
|
1992
|
1 |
3 |
p. 147-
1 p.
|
artikel
|
| 44 |
Implications of unifocal breast cancer for conserving therapy
|
Holland, R.
|
|
1992
|
1 |
3 |
p. 150-151
2 p.
|
artikel
|
| 45 |
Imprint cytology in conservative surgical management of breast cancer — A way out of the woods?
|
Desai, AJ
|
|
1992
|
1 |
3 |
p. 164-
1 p.
|
artikel
|
| 46 |
Interaction of heat shock proteins and steroid receptors in breast cancer cells
|
Leake, Robin
|
|
1992
|
1 |
3 |
p. 154-
1 p.
|
artikel
|
| 47 |
Interactions between fibroblasts and breast cancer cells in an in vitro co-culture model
|
Orr, DJA
|
|
1992
|
1 |
3 |
p. 153-
1 p.
|
artikel
|
| 48 |
Lack of prognostic significance of DNA Ploidy and S phase fraction in human breast cancer
|
Stanton, PD
|
|
1992
|
1 |
3 |
p. 148-
1 p.
|
artikel
|
| 49 |
Linkage mapping in familial breast cancer: Improved localisation of a susceptibility locus on chromosome 17Q12-21
|
Porter, DE
|
|
1992
|
1 |
3 |
p. 156-
1 p.
|
artikel
|
| 50 |
Marker biopsy of 268 impalpable breast lesions: An audit of the radiological, pathological and surgical aspects
|
Turner, GM
|
|
1992
|
1 |
3 |
p. 157-
1 p.
|
artikel
|
| 51 |
Metabolic activation of food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MelQ) to DNA binding species in human mammary epithelial cells
|
Pfau, W.
|
|
1992
|
1 |
3 |
p. 153-
1 p.
|
artikel
|
| 52 |
Metallothionein expression in human breast cancer
|
Pereira, H
|
|
1992
|
1 |
3 |
p. 159-160
2 p.
|
artikel
|
| 53 |
National approaches to breast cancer screening — Italy
|
Ciatto, S.
|
|
1992
|
1 |
3 |
p. 138-139
2 p.
|
artikel
|
| 54 |
Non-operative management of discrete palpable breast lumps in women over 35 years of age
|
Galea, MH
|
|
1992
|
1 |
3 |
p. 164-165
2 p.
|
artikel
|
| 55 |
Oestrone-3-methylphosphonothioate (E1MPT) is a potent inhibitor of oestrone sulphatase activity in MCF-7 human breast cancer cells
|
Purohit, A.
|
|
1992
|
1 |
3 |
p. 161-162
2 p.
|
artikel
|
| 56 |
Oncosuppressor genes in breast cancer
|
Imam, SA
|
|
1992
|
1 |
3 |
p. 160-
1 p.
|
artikel
|
| 57 |
Oral contraceptives at a young age and subsequent breast cancer
|
McPherson, K.
|
|
1992
|
1 |
3 |
p. 158-
1 p.
|
artikel
|
| 58 |
Plastic and reconstructive surgery: An atlas
|
Petit, J.Y.
|
|
1992
|
1 |
3 |
p. 143-
1 p.
|
artikel
|
| 59 |
Post-mastectomy radiotherapy in patients at high risk of locoregional recurrence: A randomized trial
|
Morgan, D.A.L.
|
|
1992
|
1 |
3 |
p. 151-
1 p.
|
artikel
|
| 60 |
Primary medical (neoadjuvant) chemotherapy for operable breast cancer: Building on early promise
|
Smith, IE
|
|
1992
|
1 |
3 |
p. 162-
1 p.
|
artikel
|
| 61 |
Prospective assessment of the role of four serum markers in patients with advanced breast cancer
|
Clinton, O.
|
|
1992
|
1 |
3 |
p. 165-
1 p.
|
artikel
|
| 62 |
PS2 protein status: an accurate guide to worthwhile response to tamoxifen in the over 70 age group
|
Wilson, Y.
|
|
1992
|
1 |
3 |
p. 155-
1 p.
|
artikel
|
| 63 |
Quality of life in elderly women with breast cancer
|
Fallowfield, LJ
|
|
1992
|
1 |
3 |
p. 163-
1 p.
|
artikel
|
| 64 |
Quantitation of aromatase cytochrome P450 mRNA levels in human breast tumours, using a comparative PCR technique
|
Aitken, J.
|
|
1992
|
1 |
3 |
p. 161-
1 p.
|
artikel
|
| 65 |
Randomised trial comparing zoladex∗ with nolvadex∗ plus zoladex in pre-menopausal advanced breast cancer
|
Kaufmann, M
|
|
1992
|
1 |
3 |
p. 154-155
2 p.
|
artikel
|
| 66 |
Responses to Tamoxifen withdrawal and second line endocrine therapy — Clinical clues to the mechanisms of Tamoxifen failure in patients with advanced breast cancer
|
DeFriend, DJ
|
|
1992
|
1 |
3 |
p. 166-
1 p.
|
artikel
|
| 67 |
Scottish conservation trials
|
Stewart, Helen J.
|
|
1992
|
1 |
3 |
p. 151-
1 p.
|
artikel
|
| 68 |
Second-line endocrine therapy in elderly women with breast cancer failing to respond to tamoxifen: is it worthwhile?
|
Gaskell, D.J.
|
|
1992
|
1 |
3 |
p. 132-134
3 p.
|
artikel
|
| 69 |
Sequential flow cytometry as a method of predicting response and relapse to primary medical therapy in breast cancer
|
Fernando, IN
|
|
1992
|
1 |
3 |
p. 149-
1 p.
|
artikel
|
| 70 |
Serum and intra-tumoural tamoxifen concentrations following short-term therapy in human primary breast cancer
|
Johnston, SRD
|
|
1992
|
1 |
3 |
p. 154-
1 p.
|
artikel
|
| 71 |
Short term tamoxifen induces the cytoplasmic expression of c-erbB2 and BCL-2 in er-positive human primary breast cancer
|
Johnston, SRD
|
|
1992
|
1 |
3 |
p. 166-
1 p.
|
artikel
|
| 72 |
Should the axilla be dissected in screen detected breast cancer?
|
Walls, J
|
|
1992
|
1 |
3 |
p. 162-
1 p.
|
artikel
|
| 73 |
Significant variations in breast tissue patterns betwen Asian and Caucasian women resident in southern derbyshire
|
Cohen, MEL
|
|
1992
|
1 |
3 |
p. 158-
1 p.
|
artikel
|
| 74 |
Single or multiple tumour markers for the assessment of response and progression on chemotherapy for advanced breast cancer?
|
Barratt, J
|
|
1992
|
1 |
3 |
p. 165-
1 p.
|
artikel
|
| 75 |
Slide atlas of diagnostic oncology (volume 6 ‘breast cancer’)
|
Ellis, I.O.
|
|
1992
|
1 |
3 |
p. 143-
1 p.
|
artikel
|
| 76 |
Studies on the immunohistochemical demonstration of P53 protein in inherited breast cancers correlated with evidence of mutation in the P53 gene
|
Barnes, DL
|
|
1992
|
1 |
3 |
p. 157-
1 p.
|
artikel
|
| 77 |
Surgery versus tamoxifen in selected elderly patients with operable breast cancer: Early results of a randomised trial
|
Cannon, P.M.
|
|
1992
|
1 |
3 |
p. 163-
1 p.
|
artikel
|
| 78 |
Tamoxifen alone is not adequate treatment for most elderly patients with operable breast cancer
|
Bates, T
|
|
1992
|
1 |
3 |
p. 157-
1 p.
|
artikel
|
| 79 |
Tamoxifen and castration in addition to cytotoxics in the treatment of premenopausal patients with metastatic breast cancer
|
Rose, C
|
|
1992
|
1 |
3 |
p. 162-
1 p.
|
artikel
|
| 80 |
Ten year results of the CRC adjuvant breast trial
|
Riley, D
|
|
1992
|
1 |
3 |
p. 162-163
2 p.
|
artikel
|
| 81 |
The effect of chemotherapy on cell morphology and proliferation in breast carcinoma
|
Rasbridge, SA
|
|
1992
|
1 |
3 |
p. 147-
1 p.
|
artikel
|
| 82 |
The effects of primary systemic treatment (PST) on surgical complications associated with modified radical mastectomy (MX): A randomised study
|
Forouhi, P
|
|
1992
|
1 |
3 |
p. 151-
1 p.
|
artikel
|
| 83 |
The evaluation of loading-doses of medroxyprogesterone acetate (MPA) with two different maintenance schedules in advanced breast cancer: An interim report
|
Clinton, O.
|
|
1992
|
1 |
3 |
p. 154-
1 p.
|
artikel
|
| 84 |
The genetic fingerprinting of breast cancers
|
O'Rourke, S.
|
|
1992
|
1 |
3 |
p. 156-
1 p.
|
artikel
|
| 85 |
The histochemical quantitation proliferation of invasive breast carcinomas after in vivo bromodeoxyuridine labelling
|
Rew, DA
|
|
1992
|
1 |
3 |
p. 148-
1 p.
|
artikel
|
| 86 |
The role of basic fibroblast growth factor (bFGF) and it's receptor in human breast cancer
|
Bundred, NJ
|
|
1992
|
1 |
3 |
p. 152-153
2 p.
|
artikel
|
| 87 |
The role of interleukin-6 in regulating breast tissue aromatase activity
|
Reed, MJ
|
|
1992
|
1 |
3 |
p. 161-
1 p.
|
artikel
|
| 88 |
The timing of breast cancer surgery with menstrual cycle
|
Corder, AP
|
|
1992
|
1 |
3 |
p. 152-
1 p.
|
artikel
|
| 89 |
The TNM staging of breast cancer should be abandoned
|
Barr, LC
|
|
1992
|
1 |
3 |
p. 158-159
2 p.
|
artikel
|
| 90 |
The tumour suppressor gene status of conditionally immortalised human mammary epithelial cell-lines
|
Stamps, A.C.
|
|
1992
|
1 |
3 |
p. 153-
1 p.
|
artikel
|
| 91 |
The use of a prognostic index in the management of advanced breast cancer
|
Robertson, JFR
|
|
1992
|
1 |
3 |
p. 147-
1 p.
|
artikel
|
| 92 |
The value of relative risks and absolute benefits when assessing treatment benefits for patients given tamoxifen in a randomised clinical trial
|
Riley, DL
|
|
1992
|
1 |
3 |
p. 151-152
2 p.
|
artikel
|
| 93 |
4th international conference on adjuvant therapy of primary breast cancer — St Gallen, Switzerland, 26–29 February 1992
|
Brambilla, C.
|
|
1992
|
1 |
3 |
p. 141-142
2 p.
|
artikel
|
| 94 |
Timing of surgery for breast cancer and menstrual cycle
|
Sainsbury, JRC
|
|
1992
|
1 |
3 |
p. 152-
1 p.
|
artikel
|
| 95 |
Treatment of screen-detected breast cancers— Conservation or Mastectomy — The patient's view
|
Wilson, RG
|
|
1992
|
1 |
3 |
p. 157-
1 p.
|
artikel
|
| 96 |
Type I IGF receptor levels and the control of breast cancer cell proliferation
|
Daws, MR
|
|
1992
|
1 |
3 |
p. 152-
1 p.
|
artikel
|
| 97 |
Ultrasound evaluation of 140 palpable masses in radiopaque breast
|
Cosmacini, P.
|
|
1992
|
1 |
3 |
p. 129-131
3 p.
|
artikel
|
Tijdschrift beschrijving